Lineage Cell Therapeutics (LCTX) EPS (Basic) (2010 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly EPS (Basic) came in at -$0.02 in Q1 2026, up 34.81% year-on-year from -$0.01 in Q1 2025, and up 22.37% quarter-over-quarter from -$0.03 in Q4 2025.
Lineage Cell Therapeutics (LCTX) EPS (Basic) (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.02 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 34.81% year-over-year to -$0.02 in Q1 2026; TTM through Mar 2026 was -$0.21, a 154.79% decrease from a year earlier, with the FY2025 full-year figure at -$0.28, down 196.67% from the prior year.
- EPS (Basic) climbed to -$0.02 in Q1 2026 per LCTX's latest filing, from -$0.03 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.02 in Q3 2024 and bottomed at -$41.81 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.03 (2024), against an average of -$2.49.
- Biggest YoY gain for EPS (Basic) was 99.98% in 2022; the steepest drop was 458211.28% in 2022.
- Year by year, EPS (Basic) stood at -$0.04 in 2022, then grew by 26.66% to -$0.03 in 2023, then surged by 40.54% to -$0.02 in 2024, then slumped by 55.82% to -$0.03 in 2025, then climbed by 22.37% to -$0.02 in 2026.
- Per Business Quant, the three latest LCTX EPS (Basic) figures stand at -$0.02 (Q1 2026), -$0.03 (Q4 2025), and -$0.08 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -0.08 |
| Jun 30, 2025 | -0.10 |
| Mar 31, 2025 | -0.03 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.04 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -41.81 |
| Dec 31, 2021 | -170.27 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -30.48 |